Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05885594 · ClinicalTrials.gov registry record · Early Phase 1

Imaging Inflammation With Alcohol Use Disorder: an [18F]NOS Study

A Early Phase 1 study of Alcohol Use Disorder, sponsored by University of Pennsylvania.

Active
Registry status
Early Phase 1
Development phase
4
Enrollment target
1
Study location

NCT05885594 is a Early Phase 1 study of Alcohol Use Disorder that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 4 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05885594, a Early Phase 1 study of Alcohol Use Disorder, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
Early Phase 1
Development phase
4 participants
Enrollment target
1
Study location

Study Summary

Study to enroll up to 90 individuals, those with an alcohol use disorder (AUD) (up to n=60) and non-dependent healthy volunteers (HV) (up to n=30). PET/CT imaging will be used to evaluate brain and whole-body inflammation using the investigational radiotracer \[18F\]NOS. All participants will have one \[18F\]NOS positron emission tomography/ computed tomography (PET/CT) scan performed.

Conditions Studied

Interventions

  • DRUG [18F]NOS

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2023-08-08
Est. Completion 2027-03-15
Phase Early Phase 1

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT05885594

The ClinicalTrials.gov registry entry for NCT05885594 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which [18F]NOS is the first listed.

NCT05885594 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05885594 about?

NCT05885594 is a clinical study titled "Imaging Inflammation With Alcohol Use Disorder: an [18F]NOS Study". Study to enroll up to 90 individuals, those with an alcohol use disorder (AUD) (up to n=60) and non-dependent healthy volunteers (HV) (up to n=30). PET/CT imaging will be used to evaluate brain and whole-body inflammation using the investigational radiotracer \[18F\]NOS. All participants will have...

What is the current status of trial NCT05885594?

This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 4 participants. The study started on 2023-08-08. Estimated completion is 2027-03-15.

What conditions does trial NCT05885594 study?

This clinical trial studies the following conditions: Alcohol Use Disorder.

What interventions are being tested in trial NCT05885594?

The interventions under investigation include: [18F]NOS (DRUG).

Who is sponsoring clinical trial NCT05885594?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05885594 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.